312 related articles for article (PubMed ID: 33553243)
1. Development and External Validation of a Novel Immune Checkpoint-Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma.
Zhao E; Chen S; Dang Y
Front Mol Biosci; 2020; 7():620765. PubMed ID: 33553243
[No Abstract] [Full Text] [Related]
2. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a novel immune-related prognostic model in hepatocellular carcinoma.
Wang Z; Zhu J; Liu Y; Liu C; Wang W; Chen F; Ma L
J Transl Med; 2020 Feb; 18(1):67. PubMed ID: 32046766
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma.
Du Y; Gao Y
BMC Cancer; 2020 Sep; 20(1):887. PubMed ID: 32938429
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analyses of key genes involved in hepatocellular carcinoma immunosuppression.
Huang H; Hu Y; Guo L; Wen Z
Oncol Lett; 2021 Dec; 22(6):830. PubMed ID: 34691257
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis reveals a metabolic ten-gene signature in hepatocellular carcinoma.
Zhu Z; Li L; Xu J; Ye W; Chen B; Zeng J; Huang Z
PeerJ; 2020; 8():e9201. PubMed ID: 32518728
[TBL] [Abstract][Full Text] [Related]
7. Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma.
Chen S
DNA Cell Biol; 2021 Feb; 40(2):359-372. PubMed ID: 33290144
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma.
Lin Z; Xu Q; Song X; Zeng Y; Zeng L; Zhao L; Xu J; Miao D; Chen Z; Yu F
Front Oncol; 2022; 12():748557. PubMed ID: 35311113
[TBL] [Abstract][Full Text] [Related]
9. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Zhao QJ; Zhang J; Xu L; Liu FF
World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
[TBL] [Abstract][Full Text] [Related]
10. Identification and external validation of a prognostic signature associated with DNA repair genes in gastric cancer.
Chen S; Liu W; Huang Y
Sci Rep; 2021 Mar; 11(1):7141. PubMed ID: 33785812
[TBL] [Abstract][Full Text] [Related]
11. Cuproptosis-related immune checkpoint gene signature: Prediction of prognosis and immune response for hepatocellular carcinoma.
Cong T; Luo Y; Liu Y; Yang C; Yang H; Li Y; Li J; Li X
Front Genet; 2022; 13():1000997. PubMed ID: 36276933
[TBL] [Abstract][Full Text] [Related]
12. A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma.
Liu J; Lu J; Li W
Stem Cells Int; 2021; 2021():5546032. PubMed ID: 34188686
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma.
Liang J; Zhi Y; Deng W; Zhou W; Li X; Cai Z; Zhu Z; Zeng J; Wu W; Dong Y; Huang J; Zhang Y; Xu S; Feng Y; Ding F; Zhang J
PeerJ; 2021; 9():e11627. PubMed ID: 34178478
[TBL] [Abstract][Full Text] [Related]
14. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
Xie H; Liu S; Zhang Z; Chen P; Tao Y
J Cancer; 2020; 11(19):5768-5781. PubMed ID: 32913470
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Model Based on a Six-Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
Li W; Lu J; Ma Z; Zhao J; Liu J
Front Genet; 2019; 10():1323. PubMed ID: 32010188
[No Abstract] [Full Text] [Related]
16. A Novel Angiogenesis-Related Prognostic Signature Associated with the Hepatocellular Carcinoma Immune Microenvironment and Survival Outcome.
Jiang X; Xu Y; Chen D; Wang M; Qiu M; Xiong L; Zhang L; Yu H; Xiong Z
Int J Gen Med; 2022; 15():311-323. PubMed ID: 35027841
[TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
Front Oncol; 2020; 10():780. PubMed ID: 32587825
[No Abstract] [Full Text] [Related]
18. A robust nine-gene prognostic signature associated with tumour doubling time for hepatocellular carcinoma.
Huo J; Wu L; Zang Y
Life Sci; 2020 Nov; 260():118396. PubMed ID: 32918973
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma.
Weng J; Zhou C; Zhou Q; Chen W; Yin Y; Atyah M; Dong Q; Shi Y; Ren N
J Hepatocell Carcinoma; 2021; 8():193-209. PubMed ID: 33824863
[TBL] [Abstract][Full Text] [Related]
20. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]